MACROLIDE DERIVATIVE

The purpose of the present invention is to provide a novel compound useful for the prevention or treatment of diseases such as cancerous angiogenesis, chronic rheumatoid arthritis, intimal hyperplasia, vascular atherosclerosis, hemorrhagic stroke, acute myocardial infarction, chronic heart failure,...

Full description

Saved in:
Bibliographic Details
Main Authors ASANO, YASUO, TANIKAWA, TETSUYA, KASHIMURA, MASATO, OGITA, HARUHISA, KUBO, TAKEKAZU, KAWAMURA, MADOKA
Format Patent
LanguageEnglish
French
Japanese
Published 17.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The purpose of the present invention is to provide a novel compound useful for the prevention or treatment of diseases such as cancerous angiogenesis, chronic rheumatoid arthritis, intimal hyperplasia, vascular atherosclerosis, hemorrhagic stroke, acute myocardial infarction, chronic heart failure, aneurysm, cancer metastasis, adult respiratory distress syndrome, asthma, idiopathic pulmonary fibrosis, chronic sinusitis, bronchitis or chronic obstructive pulmonary disease, or a pharmaceutically acceptable salt thereof. The present invention provides a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. La présente invention concerne un composé inédit pouvant être utilisé en vue de la prévention ou du traitement de maladies telles que l'angiogenèse associée au cancer, la polyarthrite rhumatoïde, l'hyperplasie intimale, l'athérosclérose, l'attaque d'apoplexie hémorragique, l'infarctus aigu du myocarde, l'insuffisance cardiaque chronique, l'anévrisme, les métastases cancéreuses, le syndrome de détresse respiratoire aiguë de l'adulte, l'asthme, la fibrose pulmonaire idiopathique, la sinusite chronique, la bronchite ou la bronchopneumopathie chronique obstructive ; ou un sel pharmaceutiquement acceptable de celui-ci. La présente invention concerne, donc, un composé de formule (I) ou un sel pharmaceutiquement acceptable de celui-ci.
Bibliography:Application Number: WO2012JP67987